SD Biosensor, Inc, an in-vitro diagnostic company, provides point-of-care diagnostic solutions in South Korea and internationally. The company’s products include STANDARD Q, which provides various rapid test parameters comprising COVID-19 products and other parameters; STANDARD F, a multi-parametric and random accessible FIA system that provides diagnostic results to the laboratories; and STANDARD E, an enzyme linked immunosorbent assay for mass screening tests. Its products also include STANDARD M, a point-of-care MDx system for clinical decision making near-the-patient, which include analyzers, assay menus, qPCR reagents, and NA extraction kits; procell Dx, an in vitro diagnostic products for the diagnosis of infectious disease, such as tuberculosis and SARS-CoV-2, and for checking the immune status of individuals through the interferon gamma release assay; and blood glucose meters. The company was founded in 2010 and is headquartered in Suwon-si, South Korea.
तुलना करने के लिए मीट्रिक्स | 137310 | क्षेत्र सेक्टर - संबंधित क्षेत्र की कंपनियों के व्यापक समूह से मेट्रिक्स का औसत हेल्थकेयर | संबंध संबंध137310पीअर्सक्षेत्र | |
|---|---|---|---|---|
पी/ई अनुपात | 9.2x | 10.6x | −0.6x | |
PEG अनुपात | 0.03 | 0.33 | 0.00 | |
क़ीमत/बुक | 0.3x | 1.1x | 2.6x | |
क़ीमत / एलटीएम बिक्री | 1.5x | 1.7x | 3.3x | |
अपसाइड (विश्लेषक लक्ष्य) | 3.3% | 38.3% | 40.0% | |
उचित मूल्य अपसाइड | अनलॉक करें | 32.5% | 3.2% | अनलॉक करें |